# Efficacy of B7A BSIgG Against E. Coli Strain B7A Challenge

> **NCT03040687** · PHASE1 · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 60 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **BIOLOGICAL:** Anti CS6 BSIgG product (Lot PD1601105CS)
- **BIOLOGICAL:** Anti B7A BSIgG product (Lot PD1601132ET)
- **BIOLOGICAL:** Bovine Immunoglobin Negative Control (Lot PD161071NC)
- **BIOLOGICAL:** B7A- CS6-expressing ETEC challenge strain

## Key facts

- **NCT ID:** NCT03040687
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-04
- **Final completion:** 2017-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-06-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03040687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03040687, "Efficacy of B7A BSIgG Against E. Coli Strain B7A Challenge". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03040687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*